|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.34 USD | +1.27% |
|
-2.76% | +23.07% |
| Market Cap | 1.79B 1.56B 1.44B 1.35B 2.53B 169B 2.55B 17.11B 6.63B 82.94B 6.7B 6.56B 288B | P/E 2026 * |
-10.8x | P/E 2027 * | -8.79x |
|---|---|---|---|---|---|
| Enterprise Value | 1.54B 1.34B 1.25B 1.17B 2.19B 146B 2.2B 14.78B 5.73B 71.64B 5.79B 5.67B 249B | EV / Sales 2026 * |
77.1x | EV / Sales 2027 * | - |
| Free-Float |
95.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Rapport Therapeutics, Inc.
| 1 day | +1.27% | ||
| 1 week | -2.76% | ||
| Current month | -5.47% | ||
| 1 month | +8.64% | ||
| 3 months | +35.98% | ||
| 6 months | +21.04% | ||
| Current year | +23.07% |
| 1 week | 36.46 |  | 39.98 |
| 1 month | 33.51 | | 40.72 |
| Current year | 25.21 | | 40.92 |
| 1 year | 10.5 | | 42.27 |
| 3 years | 6.43 | | 42.27 |
| 5 years | 6.43 | | 42.27 |
| 10 years | 6.43 | | 42.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Bredt
CTO | Chief Tech/Sci/R&D Officer | 61 | 2022-12-31 |
Abraham Ceesay
CEO | Chief Executive Officer | 48 | 2023-01-31 |
Troy Ignelzi
DFI | Director of Finance/CFO | 58 | 2023-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
James Healy
BRD | Director/Board Member | 61 | 2023-08-22 |
Abraham Ceesay
BRD | Director/Board Member | 48 | 2023-02-28 |
Reid Huber
BRD | Director/Board Member | 54 | 2022-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-09 | Free | Director | 15,200 | 0.0318% | ||
| 06-09 | Free | Director | 15,200 | 0.0318% | ||
| 06-09 | Free | Founder | 15,200 | 0.0318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.27% | -2.76% | +238.53% | - | 1.79B | |
| +1.44% | +1.71% | -10.63% | -9.16% | 43.13B | |
| +3.31% | +5.93% | +308.19% | +562.02% | 34.65B | |
| +2.84% | +2.14% | +6.87% | +34.93% | 30.03B | |
| -1.70% | -7.54% | +8.51% | -22.34% | 28B | |
| -1.90% | -1.56% | +11.62% | +19.80% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +52.04% | +107.47% | 13.14B | |
| -0.57% | -2.43% | +5.18% | +4.20% | 12.53B | |
| -0.26% | +1.15% | +100.27% | +80.69% | 12.25B | |
| Average | +0.50% | +1.27% | +80.07% | +97.20% | 21.43B | |
| Weighted average by Cap. | +0.78% | +1.31% | +66.77% | +113.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20M 17.44M 16.15M 15.12M 28.35M 1.89B 28.53M 192M 74.25M 929M 75.07M 73.46M 3.23B | - |
| Net income | -166M -145M -134M -126M -236M -15.7B -237M -1.59B -618M -7.73B -625M -611M -26.84B | -219M -191M -177M -166M -311M -20.7B -313M -2.1B -815M -10.19B -824M -806M -35.38B |
| Net Debt | -243M -212M -196M -184M -345M -22.96B -347M -2.33B -903M -11.3B -913M -894M -39.24B | -336M -293M -271M -254M -476M -31.7B -479M -3.22B -1.25B -15.6B -1.26B -1.23B -54.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 37.34 $ | +1.27% | 355,436 |
| 26-06-17 | 36.87 $ | -4.21% | 273,472 |
| 26-06-16 | 38.49 $ | +0.60% | 157,086 |
| 26-06-15 | 38.26 $ | -0.36% | 317,189 |
| 26-06-12 | 38.40 $ | +9.06% | 255,653 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RAPP Stock
Select your edition
All financial news and data tailored to specific country editions
